CausalSentinel

Protein Dossier — CGA (Glycoprotein hormones alpha chain)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Creatinine (enzymatic) in urine -0.0127 0.00388 0.00107 Wald ratio 1 trans NA
Alcohol intake frequency 0.0183 0.00599 0.00223 Wald ratio 1 trans NA
Age at menarche -0.0306 0.0101 0.0024 Wald ratio 1 trans NA
Fractured or broken bones in last 5 years -0.0385 0.0131 0.0034 Wald ratio 1 trans NA
Diagnoses - main ICD10: Z09 Follow-up examination after treatment for conditions other than malignant neoplasms 0.0851 0.0303 0.00495 Wald ratio 1 trans NA
Potassium in urine -0.0106 0.00411 0.00968 Wald ratio 1 trans NA
Weight -0.00912 0.00358 0.0108 Wald ratio 1 trans NA
Non-cancer illness code self-reported: kidney stone or ureter stone or bladder stone -0.129 0.0522 0.0132 Wald ratio 1 trans NA
Fractured bone site(s): Other bones -0.0441 0.0184 0.0166 Wald ratio 1 trans NA
Low grade serous ovarian cancer -0.203 0.0875 0.0201 Wald ratio 1 trans NA
Cancer code self-reported: prostate cancer -0.125 0.0539 0.0205 Wald ratio 1 trans NA
Diagnoses - main ICD10: L03 Cellulitis 0.0922 0.0412 0.0251 Wald ratio 1 trans NA
…and 79 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2953_31_2 Luteinizing hormone Suhre K 2019
prot-c-3032_11_2 FSH Suhre K 2019
prot-c-3521_16_2 TSH Suhre K 2019
prot-c-4914_10_1 HCG Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

23 association rows across 16 traits (22 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Thyroid stimulating hormone levels 5e-78 rs1998615 4 GCST90572789 no MR -> candidate analysis
Thyroid-stimulating hormone levels 3e-22 rs2031365 1 GCST90662868 no MR -> candidate analysis
White blood cell count 2e-20 rs4574603 2 GCST90002378 no MR -> candidate analysis
Circulating CGA levels 2e-18 rs2031367 1 GCST90860633 no MR -> candidate analysis
Neutrophil percentage of granulocytes 6e-18 rs67614146 1 GCST004623 no MR -> candidate analysis
CGA protein levels 4e-17 rs2031367 1 GCST90468732 no MR -> candidate analysis
FSHB protein levels 4e-15 rs779759288 1 GCST90469270 no MR -> candidate analysis
Eosinophil percentage of granulocytes 5e-15 rs67614146 1 GCST004617 no MR -> candidate analysis
Free thyroxine levels within normal range in pregnancy 1e-13 rs9362387 1 GCST90435196 no MR -> candidate analysis
Neutrophil-to-lymphocyte ratio 8e-13 rs981087 3 GCST90866310 no MR -> candidate analysis
Eosinophil percentage of white cells 6e-12 rs67614146 1 GCST004600 no MR -> candidate analysis
Educational attainment 5e-11 rs9362387 1 GCST90105038 no MR -> candidate analysis
…and 4 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 877 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hypothyroidism 0.807 common-variant locus no MR -> candidate analysis
interstitial lung disease 0.244 common-variant locus no MR -> candidate analysis
placenta praevia 0.216 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Glycoprotein hormones alpha chain)
gnomAD constraint pLI=0.6, LOEUF=0.763 — LoF-tolerant
GWAS Catalog 45 unique SNPs / 90 rows
ClinVar 35 records; 12 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance